Anastasia Armbruster, Pharm.D., FACC, BCCP
@aarmbruster09
Professor at St. Louis College of Pharmacy, Cardiology Pharmacist at Missouri Baptist Medical Center
ID: 624328243
02-07-2012 03:33:34
375 Tweet
247 Followers
327 Following
Why simultaneous, early in-🏨 initiation of foundational #GDMT should be the standard of care globally Steve Greene Javed Butler Robert Mentz, MD Clyde Yancy, MD, MSc Marco Metra
#PharmD + American College of Cardiology = 🫀 Please share with your PharmD colleagues to join ACC and the #ACCCVT this month. They will receive a 40% discount for 2023! Code: YouSave40 Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP,CACP shares about the value of being a part of ACC Ashley Schenk, PharmD, BCCP, AACC ACCP Cardiology PRN Anastasia Armbruster, Pharm.D., FACC, BCCP
Top3 heart failure trials in October 2022: #CardioTwitter 🥇Managing HF in patients on dialysis Journal of Cardiac Failure 🥈 Hydrochlorothiazide vs chlorthalidone, what is the difference? Circulation 🥉HF drug treatment ➡️Inertia, y itration, and discontinuation: EVOLUTION HF JACC Journals
American College of Cardiology update by VP B. Hadley Wilson MD at Missouri ACC chapter meeting Kathryn Lindley Toniya Singh MD FACC
American College of Cardiology Minnow Walsh, MD, MACC - Keynote - Discussing the importance of the team and team based care Kathryn Lindley B. Hadley Wilson MD Sridevi Pitta, MD,MBA Vrinda Trivedi MD FACC @AnnaGrodzinsky Anastasia Armbruster, Pharm.D., FACC, BCCP Missouri ACC
Pharmacists highlighted as a critical member of the heart team. Dr. Walsh also highlighted training and certifications clinical pharmacists complete. Missouri ACC American College of Cardiology #cvteam
Missouri ACC Dr Deana Mikhalkova discussing the Heart Failure Guidelines American College of Cardiology Minnow Walsh, MD, MACC B. Hadley Wilson MD Kathryn Lindley Sridevi Pitta, MD,MBA Santhosh Reddy Mannem MD FACC FSCAI Anastasia Armbruster, Pharm.D., FACC, BCCP
TUNA2 for antithrombotic stewardship. Does your hospital have a process for identifying which patients are at increased risk of bleeding and could benefit from ASA deprescribing or initiation of PPI. Thanks Jacob E. Kurlander for this great graphic! #ACForum23 Anticoagulation Forum
Now this is how to do an assessment of value for pharmacists' services! We need more formal CEAs like this based on patient outcomes (⬇︎BP ➡︎ ⬇︎ CVD events) & less cost-avoidance studies based on interventions made. Kudos Dave Dixon, Professor & Chair @VCUPharmacy & coauthors. jamanetwork.com/journals/jaman…
Registration now open! Join us for a discussion of how the new #AFib guidelines pertain to #anticoagulation practitioners 💓 Wednesday, Feb. 21, 12pm ET Moderators & panelists: Arthur Allen Andrea Van Beek Anastasia Armbruster, Pharm.D., FACC, BCCP ❤️🔥 Register today! bit.ly/3SFdnqT
🚨New in JACC Journals w #ACC24 🇺🇸 analysis of newly diagnosed #HFrEF >4 in 5 pts eligible for quad GDMT Yet, <1 in 6 prescribed it. Potentially completely generic triple GDMT (RASi + BB + MRA)??.....only ~4 in 10 eligible pts even prescribed this. jacc.org/doi/10.1016/j.…